Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Array Biopharma Inc (NASDAQ:ARRY)

12.88
Delayed Data
As of 4:00pm ET
 -0.31 / -2.35%
Today’s Change
6.73
Today|||52-Week Range
14.40
+0.63%
Year-to-Date
No recent news for Array Biopharma Inc.

Today’s Trading

Previous close13.19
Today’s open13.13
Day’s range12.62 - 13.20
Volume2,902,264
Average volume (3 months)3,904,746
Market cap$2.6B
Data as of 4:00pm ET, 01/18/2018

Growth & Valuation

Earnings growth (last year)-10.77%
Earnings growth (this year)-37.65%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+9.41%
P/E ratioNM
Price/Sales9.06
Price/Book192.67

Competitors

 Today’s
change
Today’s
% change
RGENRepligen Corp-0.41-1.16%
CBMCambrex Corp+2.30+4.28%
IPXLImpax Laboratories I...+0.15+0.74%
LXRXLexicon Pharmaceutic...+0.07+0.69%
Data as of 4:02pm ET, 01/18/2018

Financials

Next reporting dateFebruary 6, 2018
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$150.9M
Annual profit (last year)-$116.8M
Net profit margin-77.44%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ron Squarer
Chief Operating Officer
Andrew R. Robbins
Corporate headquarters
Boulder, Colorado

Forecasts